LCN2 and psoriasis: When validated these neutrophil activation makers and the markers of psoriasis in Figure 1C with the public datasets, we found that S100A7A, LCE3D, PLA2G4D, LCN2, IL36G and S100A9 were consistently significantly increased in lesional group (Figure S3).